A new treatment for asthma and COPD attacks could revolutionise patient care, scientists say. An injection given during ...

Argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative Medicine (PIM) status ...

How industry and the NHS can work together to bridge the diagnostic gap in COPD Lord Darzi’s recent report on the state of ...

A precise and realistic TPP can define a clear path to market and commercial success by bridging the gap between research and ...

PharmaTimes Marketer of the Year Awards and Communications Awards ...

Process efficiencies – QR codes provide a continuous gateway to the latest PI, reducing the time spent to produce and approve ...

Our luminaries look across the pharmaverse with conclusions and curiosity ...

Commit Biologics has announced the appointment of Mikkel Wandahl Pedersen as Chief Scientific Officer (CSO). Mikkel is a ...

Tessellate BIO has appointed Dr Lara Boyd as Chief Business Officer.

How the UK medical cannabis market is tackling supply chain strain ...

Imagine cruising down a highway, with the hum of the engine and road beneath you, travelling towards your destination. On the ...

We are on the cusp of a new era. With net zero hurtling up the agenda, our industry must view decarbonisation as a wider ...